Investor Opportunities

“Tmunity has a bold vision of completely transforming the future CAR-T therapies by engineering best-in-class armored T-cells with its’ novel rapid manufacturing platform to significantly reduce time to treatment and expanding the overall target patient population for CAR-T therapy"
Sujay Kango, President & CEO

Tmunity is pursuing a selective and targeted business development and licensing strategy to further enhance its ability to integrate the latest science, medicine and technology toward the creation and delivery of best-in-class cell therapies for patients with unmet medical needs.

We welcome inquiries on working with Tmunity.